Evogene Net Worth
Evogene Net Worth Breakdown | EVGN |
Evogene Net Worth Analysis
Evogene's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Evogene's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Evogene's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Evogene's net worth analysis. One common approach is to calculate Evogene's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Evogene's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Evogene's net worth. This approach calculates the present value of Evogene's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Evogene's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Evogene's net worth. This involves comparing Evogene's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Evogene's net worth relative to its peers.
To determine if Evogene is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Evogene's net worth research are outlined below:
| Evogene generated a negative expected return over the last 90 days | |
| Evogene has high historical volatility and very poor performance | |
| Evogene may become a speculative penny stock | |
| Evogene has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 5.64 M. Net Loss for the year was (25.95 M) with profit before overhead, payroll, taxes, and interest of 7.69 M. | |
| Evogene currently holds about 35.25 M in cash with (21.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86. |
Evogene uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Evogene. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Evogene's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 16th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Follow Evogene's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.1 M.Project Evogene's profitablity
The company has Profit Margin (PM) of (2.1) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (6.67) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $6.67.When accessing Evogene's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Evogene's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Evogene's profitability and make more informed investment decisions.
Evogene time-series forecasting models is one of many Evogene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Evogene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Evogene Earnings per Share Projection vs Actual
Evogene Corporate Management
| Rachel Gerber | Head Relations | Profile | |
| Amit res | Chief Ltd | Profile | |
| Dotan Borenstein | Chief Ltd | Profile | |
| Yaron Eldad | Chief Officer | Profile | |
| Eyal Ronen | Executive Development | Profile | |
| Nir Arbel | Chief Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evogene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.